Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Rabbit Ab appears to be more effective than horse Ab in the prevention of graft rejection

May 21, 1998

Interim results reported for Zenapax combination in kidney transplantation

May 20, 1998

DISC HSV reported to be safe and immunogenic in phase I trials

May 20, 1998

Safety and pharmacokinetic data reported for MEDI-507

May 19, 1998

Maxim's mucosal vaccine research published

May 18, 1998

Aviron's FluMist influenza vaccine is effective in children

May 15, 1998

FDA clears Novartis to market Simulect for use in renal transplantation

May 14, 1998

Zenapax shows promise in pediatric kidney transplantation

May 14, 1998

First market introduction for basiliximab

May 12, 1998

Enzo, Hadassah University collaborate on immunomodulating technology

May 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...